🟢 Painreform is trading 10.89% up today as indexes and biotech stocks advance

Painreform is trading 10.89% up now at $1.12, as broad risk appetite supports higher-beta stocks and major U.S. indexes and biotech stocks advance after opening-day momentum continued from the September 16, 2026 close of $1.01.

• No verified company-specific announcement was identified for September 17, 2026.
• Recent attention followed earlier healthcare and AI-energy updates, including OcuRing-K regulatory progress and DeepSolar developments.